Jonathan S. Coblyn

4.6k total citations · 1 hit paper
31 papers, 2.6k citations indexed

About

Jonathan S. Coblyn is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Jonathan S. Coblyn has authored 31 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 11 papers in Immunology and 6 papers in Genetics. Recurrent topics in Jonathan S. Coblyn's work include Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jonathan S. Coblyn is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jonathan S. Coblyn collaborates with scholars based in United States, United Kingdom and France. Jonathan S. Coblyn's co-authors include Michael E. Weinblatt, Elena Massarotti, Katherine Larabee, Éric Boilard, Gerald F. Watts, Peter A. Nigrović, Richard W. Farndale, Eileen Remold‐O’Donnell, David Lee and Jerry Ware and has published in prestigious journals such as Science, Science Translational Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Jonathan S. Coblyn

31 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production

2010 860 citations Éric Boilard, Peter A. Nigrović et al. Science profile →

Peers

Countries citing papers authored by Jonathan S. Coblyn

Since Specialization

Citations

This map shows the geographic impact of Jonathan S. Coblyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Coblyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Coblyn more than expected).

Fields of papers citing papers by Jonathan S. Coblyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Coblyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Coblyn. The network helps show where Jonathan S. Coblyn may publish in the future.

Co-authorship network of co-authors of Jonathan S. Coblyn

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Coblyn. A scholar is included among the top collaborators of Jonathan S. Coblyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Coblyn. Jonathan S. Coblyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis 2024 ·Seminars in Arthritis and Rheumatism ·Gregory C McDermott, Michael DiIorio, Yumeko Kawano, (unknown), (unknown), (unknown), Su‐Jin Moon, (unknown), Jonathan S. Coblyn, Elena Massarotti, Michael E. Weinblatt, Dana Weisenfeld, Katherine P. Liao	4
2	Pregnancy Intention Screening in Patients With Systemic Rheumatic Diseases: Pilot Testing a Standardized Assessment Tool 2022 ·ACR Open Rheumatology ·(unknown), Bill Albert, Sonali Desai, Susan Y. Ritter, Laura Tarter, Jonathan S. Coblyn, Bonnie L. Bermas, L Santacroce, Caryn Dutton, Kari P. Braaten, Lydia E. Pace, Kathryn M. Rexrode, Elizabeth Janiak, Candace H. Feldman	8
3	Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation 2020 ·Arthritis & Rheumatology ·Brittany Weber, Zhe He, Nicole Yang, Martin P. Playford, Dana Weisenfeld, Christine Iannaccone, Jonathan S. Coblyn, Michael E. Weinblatt, Nancy A. Shadick, Marcelo F. Di Carli, Nehal N. Mehta, Jorge Plutzky, Katherine P. Liao	17
4	The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study 2019 ·ACR Open Rheumatology ·Nancy A. Shadick, Patricia Katz, (unknown), (unknown), Jonathan S. Coblyn, Michael E. Weinblatt, Jing Cui	10
5	Mixed-effects association of single cells identifies an expanded effector CD4 ⁺ T cell subset in rheumatoid arthritis 2018 ·Science Translational Medicine ·Chamith Y. Fonseka, Deepak A. Rao, Nikola C. Teslovich, Ilya Korsunsky, Susan Hannes, Kamil Slowikowski, Michael F. Gurish, Laura T. Donlin, Eddie A. James, Michael E. Weinblatt, Elena Massarotti, Jonathan S. Coblyn, Simon M. Helfgott, Derrick J. Todd, Vivian P. Bykerk, Elizabeth W. Karlson, Joerg Ermann, Yvonne Lee, Michael B. Brenner, Soumya Raychaudhuri	99
6	Increasing pneumococcal vaccination for immunosuppressed patients: A cluster quality improvement trial 2012 ·Arthritis & Rheumatism ·Sonali Desai, Bing Lü, (unknown), Anna Bogdanova, Alexander Turchin, Michael E. Weinblatt, Jonathan S. Coblyn, Jeffrey O. Greenberg, Allen Kachalia, Daniel H. Solomon	45
7	Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production breakdown → 2010 ·Science ·Éric Boilard, Peter A. Nigrović, Katherine Larabee, Gerald F. Watts, Jonathan S. Coblyn, Michael E. Weinblatt, Elena Massarotti, Eileen Remold‐O’Donnell, Richard W. Farndale, Jerry Ware, David Lee	860
8	Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality 2010 ·Lara D. Veeken ·Sonali Desai, Alexander Turchin, (unknown), Michael E. Weinblatt, Jonathan S. Coblyn, David H. Solomon, Allen Kachalia	28
9	A novel anti‐inflammatory role for secretory phospholipase A ₂ in immune complex‐mediated arthritis 2010 ·EMBO Molecular Medicine ·Éric Boilard, Ying Lai, Katherine Larabee, Barbara Balestrieri, Farideh Ghomashchi, Daisuke Fujioka, Reuben Gobezie, Jonathan S. Coblyn, Michael E. Weinblatt, Elena Massarotti, Thomas S. Thornhill, Maziar Divangahi, Heinz G. Remold, Gérard Lambeau, Michael H. Gelb, P. Jonathan, David M. Lee	113
10	Prevalence of labral tears and cartilage loss in patients with mechanical symptoms of the hip: evaluation using MR arthrography 2007 ·Osteoarthritis and Cartilage ·(unknown), (unknown), Kelly H. Zou, T. Minas, Jonathan S. Coblyn, Carl S. Winalski, Philipp Lang	91
11	Multifaceted intervention to improve rheumatologists' management of glucocorticoid‐induced osteoporosis: A randomized controlled trial 2004 ·Arthritis Care & Research ·Daniel H. Solomon, Jeffrey N. Katz, (unknown), Jonathan S. Coblyn	58
12	Low prevalence of antibodies to glucose‐6‐phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders 2003 ·Arthritis & Rheumatism ·Isao Matsumoto, David M. Lee, Raphaela Goldbach‐Mansky, Takayuki Sumida, Carol Hitchon, Peter H. Schur, Ronald J. Anderson, Jonathan S. Coblyn, Michael E. Weinblatt, Michael B. Brenner, Bernard Duclos, Jean‐Louis Pasquali, Hani El‐Gabalawy, Diane Mathis, Christophe Benoıst	102
13	Management of glucocorticoid‐induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practice 2002 ·Arthritis & Rheumatism ·Daniel H. Solomon, Jeffrey N. Katz, Jonathan P. Jacobs, (unknown), Jonathan S. Coblyn	105
14	Acute and chronic suppression of leukotriene B₄ synthesis EX vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate 1992 ·Arthritis & Rheumatism ·Richard I. Sperling, (unknown), Ronald J. Anderson, Jonathan S. Coblyn, K. Frank Austen, Michael E. Weinblatt	84
15	The effects of cyclosporin a on eicosanoid excretion in patients with rheumatoid arthritis 1991 ·Arthritis & Rheumatism ·M. Weinblatt, Simon M. Helfgott, Jonathan S. Coblyn, J Spragg, (unknown), (unknown), Agnes L. Maier, Waltraud M. Uedelhoven, Robin Lorenz, Christian Weber	6
16	Inhibition of Leukotriene B₄ synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate 1990 ·Arthritis & Rheumatism ·Richard I. Sperling, Jonathan S. Coblyn, (unknown), (unknown), K. Frank Austen, Michael E. Weinblatt	60
17	The Effect of Cyclosporine on Urinary Kallikrein Excretion in Patients with Rheumatoid Arthritis 1989 ·Advances in experimental medicine and biology ·J Spragg, Jonathan S. Coblyn, Patricia A. Fraser, K. Frank Austen, M. Weinblatt	5
18	Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis 1988 ·Arthritis & Rheumatism ·Michael E. Weinblatt, David E. Trentham, Patricia A. Fraser, Donald E. Holdsworth, Kenneth R. Falchuk, Barbara N. Weissman, Jonathan S. Coblyn	192
19	Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis 1987 ·Arthritis & Rheumatism ·Richard I. Sperling, Michael E. Weinblatt, (unknown), Joseph Ravalese, Richard L. Hoover, F.R. House, Jonathan S. Coblyn, Patricia A. Fraser, Bernd W. Spur, Dwight R. Robinson, Robert A. Lewis, K. Frank Austen	175
20	Thrombotic thrombocytopenic purpura and systemic lupus erythematosus. 1986 ·Annals of the Rheumatic Diseases ·David A. Fox, James D. Faix, Jonathan S. Coblyn, Patricia A. Fraser, Benjamin J. Smith, Michael E. Weinblatt	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact